Actionnariat et activité des initiés pour BrainsWay Ltd. (BWAY): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $13.46 |
| Capitalisation | $528M |
| Bourse | NASDAQ |
| Pays | IL |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $9.2M | $14.5M | $9.0M | $21.7M | $17.0M | $16.9M | $47.6M | $10.5M | $69.3M | $67.7M |
| Placements à Court Terme | 0 | 0 | 0 | $221000 | $221000 | $40.4M | 0 | $35.5M | 0 | $1.4M |
| Créances | $2.9M | $2.9M | $4.0M | $6.0M | $5.8M | $6.3M | $4.8M | $3.8M | $4.6M | $4.1M |
| Stocks | $585000 | $271000 | $91000 | $306000 | $442000 | $200000 | $3.8M | $3.7M | $4.4M | $7.1M |
| Actifs Courants | $13.1M | $17.9M | $13.5M | $28.8M | $24.3M | $65.4M | $58.1M | $55.5M | $79.7M | $84.9M |
| Immobilisations Corporelles | $6.8M | $7.1M | $7.6M | $15.2M | $9.6M | $9.3M | $5.3M | $5.8M | $11.9M | $12.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $9000 | $18000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $20.0M | $27.0M | $23.6M | $38.7M | $34.0M | $75.7M | $64.5M | $63.0M | $94.3M | $112.9M |
| Dettes Fournisseurs | $810000 | $1.6M | $2.2M | $1.3M | $781000 | $1.1M | $1.1M | $758000 | $2.9M | $2.4M |
| Dette à Court Terme | $810000 | 0 | $750000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $4.4M | $6.1M | $8.3M | $6.7M | $6.8M | $9.1M | $8.1M | $9.8M | $15.3M | $22.2M |
| Dette à Long Terme | 0 | $2.7M | $2.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $9.7M | $14.3M | $16.6M | $14.5M | $14.4M | $18.4M | $19.1M | $21.4M | $32.0M | $39.7M |
| Réserves | -$48.0M | -$55.1M | -$61.6M | -$71.9M | -$77.3M | -$83.8M | -$97.1M | -$101.3M | -$98.4M | -$90.7M |
| Capitaux Propres | $10.3M | $12.7M | $7.0M | $24.2M | $19.6M | $57.3M | $45.4M | $41.6M | $62.3M | $73.2M |
| Dette Totale | $810000 | $2.7M | $2.8M | $414000 | $672000 | $754000 | $488000 | $471000 | $5.6M | $6.8M |
| Dette Nette | -$8.4M | -$11.8M | -$6.1M | -$21.5M | -$16.5M | -$56.6M | -$47.1M | -$45.5M | -$63.7M | -$62.3M |
| Fonds de Roulement | $8.7M | $11.8M | $5.1M | $22.1M | $17.5M | $56.4M | $49.9M | $45.7M | $64.3M | $62.7M |
Santé financière
| Dette / Capitaux propres | 0.09 |
| Ratio de liquidité | 3.59 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.87 |
Rentabilité
| Rentabilité des capitaux propres | 12.69% |
| Rentabilité du capital investi | 7.71% |
| Rentabilité des actifs | 7.76% |
| Marge brute | 75.33% |
| Marge opérationnelle | 12.18% |
| Marge nette | 14.61% |
Entreprises liées: CERS · CVRX · DCTH · MASS · NPCE · RXST · SENS
Explorer le secteur: Healthcare · Medical - Specialties
Plus de sections de BWAY: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions